Telix Pharmaceuticals (TLPPF) Q4 2021 Earnings Report
TLPPF Q4 2021 EPS Results
- Actual EPS
- -$0.12
- Consensus EPS
- -$0.05
- Beat/Miss
- Missed by -$0.07
- One Year Ago EPS
- -$0.08
TLPPF Q4 2021 Revenue Results
- Actual Revenue
- $3.31M
- Expected Revenue
- $2.38M
- Beat/Miss
- Beat by +$923.55K
- YoY Revenue Growth
- +29.95%
Earnings Announcement Details
- Quarter
- Q4 2021
- Date
- 02/23/2022
- Time
- After Close
- Conference Call
- Wednesday, February 23, 2022
TLPPF Upcoming Earnings
Telix Pharmaceuticals's next earnings date is estimated for February 19, 2027, based on past reporting schedules.
Q4 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
TLPPF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 19, 2027 | 2026 (Q4) | 0.06- | -0.01 | ― | ― |
| Aug 19, 2026 | 2026 (Q2) | 0.020.17 | 0.01 | 1600.00% (+0.16) | |
| Feb 19, 2026 | 2025 (Q4) | 0.04-0.01 | 0.04 | -131.58% (-0.05) | |
| Aug 20, 2025 | 2025 (Q2) | 0.180.01 | 0.06 | -83.61% (-0.05) | |
| Feb 20, 2025 | 2024 (Q4) | 0.040.04 | 0.04 | 2.70% (+0.00) | |
| Aug 22, 2024 | 2024 (Q2) | 0.100.06 | -0.03 | 310.34% (+0.09) | |
| Feb 22, 2024 | 2023 (Q4) | 0.050.04 | -0.02 | 331.25% (+0.05) | |
| Aug 23, 2023 | 2023 (Q2) | 0.04-0.03 | -0.16 | 81.88% (+0.13) | |
| Apr 17, 2023 | 2023 (Q1) | ―- | -0.12 | ― | |
| Feb 27, 2023 | 2022 (Q4) | -0.05-0.02 | -0.12 | 86.67% (+0.10) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
